Research News

National Glaucoma Research

Harnessing the power of artificial intelligence, researchers have identified nearly 200 previously unknown DNA regions linked to a risk of developing glaucoma, findings that could lead to new ways of preventing the disease. 

Aug 3, 2023
National Glaucoma Research

Initial study results of an innovative glaucoma therapy involving eye implants have yielded positive results, and a Phase 2 clinical trial of this exciting potential treatment has begun.

Jun 29, 2023
National Glaucoma Research

BrightFocus-funded research offers the potential to restore vision loss due to glaucoma using cell replacement therapy.

Apr 3, 2023
National Glaucoma Research

A team of BrightFocus-funded scientists has proposed a new explanation and possible new target for treatment in glaucoma that’s unrelated to the common culprit of eye pressure.

Dec 1, 2022
National Glaucoma Research

Jason Meyer, PhD, is a BrightFocus Foundation success story and a pioneer in the effort to regenerate eye tissue that is damaged by glaucoma. 

Sep 29, 2022
Research News

Recently, when their groundbreaking genetics discovery was featured on the cover of Nature, the research team thanked BrightFocus for critical early funding that supported their accomplishments.

Apr 13, 2021
Research News

An interdisciplinary team of Harvard scientists has successfully reprogrammed cells in mice to reverse vision loss from glaucoma, as well as normal (not disease-related) vision loss associated with aging in mouse models.

Apr 1, 2021
Research News
Working to save sight, BrightFocus’ National Glaucoma Research program is supporting Kathryn Burdon, PhD, of Australia’s University of Tazmania and Girum Gessesse, MD, of Ethiopia’s St. Paul’s Hospital Millennium Medical College to expand our scientific understanding of glaucoma in Africa.
Oct 7, 2020
Research News
The research and discoveries of clinician-scientist Joel S. Schuman, MD, are having a big impact on vision diseases, including glaucoma. Early support from BrightFocus had a big impact on his career.
Jul 23, 2019
Research News

Two new pressure-lowering glaucoma medications have been approved by the FDA and are becoming available in the United States. Each is unique, and one is the first in a new class of drugs.

Mar 29, 2018